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Comparison of methods to predict equilibrated Kt/V in the HEMO
Pilot Study. The ongoing HEMO Study, a National Institutes of Health
(NIH) sponsored multicenter trial to test the effects of dialysis dosage and
membrane flux on morbidity and mortality, was preceded by a Pilot Study
(called the MMHD Pilot Study) designed to test the reliability of methods
for quantifying hemodialysis. Dialysis dose was defined by the fractional
urea clearance per dialysis determined by the predialysis BUN and the
equilibrated postdialysis BUN after urea rebound is completed (eKt/V).
In the Pilot Study the blood side standard for eKt/V was calculated from
the predialysis, postdialysis, and 30-minute postdialysis BUN. Four tech-
niques of approximating eKt/V that eliminated the requirement for the
30-minute postdialysis sample were also evaluated. The first adjusted
the single compartment Kt/V using a linear equation with slope based
on the relative rate of solute removal (K/V) to predict eKt/V (rate
method). The second and third techniques used equations or mathemat-
ical curve fitting algorithms to fit data that included one or more samples
drawn during dialysis (intradialysis methods). The fourth technique (dia-
lysate-side) predicted eKt/V from an analysis of the time-dependent
profile of dialysate urea nitrogen concentrations (BioStat method; Baxter
Healthcare, Inc., Round Lake, IL, USA). The Pilot Study demonstrated
the feasibility of conventional and high dose targets of about 1.0 and 1.4
for eKt/V. Based on the blood side standard method, the mean so
eKt/V for patients randomized to these targets was 1.14 0.11 and 1.52
0.15 (N = 19 and 16 patients, respectively). Single-pool Kt/Vs were about
0.2 Kt/V units higher. Results were similar when eKt/V was based on
dialysate side measurements: 1.10 0.11 and 1.50 0.11. The approxi-
mations of eKt/V by the three blood side methods that eliminated the
delayed 30-minute post-dialysis sample correlated well with eKt/V from
the standard blood side method: r = 0.78 and 0.76 for the single-sample
(Smye) and multiple-sample intradialysis methods (N = 295 and 229
sessions, respectively) and 0.85 for the rate method (N = 295). The
median absolute difference between eKt/V computed using the standard
blood side method and eKt/V from the four other methods ranged from
0.064 to 0.097, with the smallest difference (and hence best accuracy) for
the rate method. The results suggest that, in a dialysis patient population
selected for ability to achieve an equilibrated Kt/V of about 1.45 in less
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than a 4.5 hour period, use of the pre and postdialysis samples and a
kinetically derived rate equation gives reasonably good prediction of
equilibrated Kt/V. Addition of one or more intradialytic samples does not
appear to increase accuracy of predicting the equilibrated Kt/V in the
majority of patients. A method based on dialysate urea analysis and
curve-fitting yields results for equilibrated Kt/V that are similar to those
obtained using exclusively blood-based techniques of kinetic modeling.
End-stage renal disease (ESRD) is a critically important health
care problem in the United States. Despite advances in the
prevention and treatment of renal disease, the size of the ESRD
program continues to increase. The majority of patients with
ESRD are treated by hemodialysis. The gross mortality rate
among dialysis patients is 23% per year [1], despite long experi-
ence with treatment and improvement in technical aspects of the
dialysis procedure. In an attempt to establish interventions to
improve survival of hemodialysis patients, the United States
National Institutes of Health has sponsored the HEMO Study,
which is now ongoing. This is a multicenter, prospective, random-
ized trial designed to assess the effect of hemodialysis dose and
flux on morbidity and mortality. One primary hypothesis to be
tested in the study is that a higher dose of dialysis [urea reduction
ratio (URR) in the range of 75%, single pool Kt/V of about 1.65,
equilibrated Kt/V of 1.45] may reduce morbidity and/or mortality
as compared to a standard amount of dialysis (URR of about
67%, a single-pool Kt/V of about 1.25, equilibrated Kt/V of 1.05.)
The second primary hypothesis to be tested is that the use of high
flux membranes may reduce morbidity and/or mortality.
The HEMO Study was preceded by a Pilot Study, the MMHD
(Mortality and Morbidity in Hemodialysis) Study, among the
purposes of which was the evaluation of various methods of
assessing urea removal during hemodialysis. Of greatest concern
was the rebound in urea concentration at the end of the treat-
ment. Rebound is due to the non-uniform distribution of urea and
other solutes among various body compartments that develops
during dialysis and reflects diminished solute removal during
dialysis. Any technique that is proposed to quantify dialysis
accurately must include the rebound component. At the time the
Pilot Study was launched, data were available suggesting that
post-dialysis urea rebound may be highly variable among patients,
and even within the same patient from treatment to treatment {2,
3]. To insure accuracy, direct measurement of the post-dialysis
equilibrated BUN (measured after rebound was largely complete)
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Table I. Pilot Study Urea Kinetic Modeling
Baseline Follow-up
Target eKt/V Target eKt/VTarget eKt/V
Usual Rx 1.4 1.0 1.4
N of dialyses
N of patients
Oh oil/mm
Kd mlmmn
miii
Urea volumes liter
(a) Single-pool
(b) Antbropometrie
ratio of a/b
Kt/V measures
(a) Single-pool
(h) True equilibrium, eKt/Vd
(e) BioStat
(d) a — b
(e) 0.6K/V 0.03 (Rate Eq)
(f)d e
144
48
391 (43)
245 (27)
210 (27)
35.1 (6.4)
35.9 (7.1)
0.99 (0.14)
1.50 (0.21)
1.28 (0.19)
1.33 (0.23)
0.217 (0.099)
0.231 (0.051)
—0.014 (0.089)
87
46
415 (45)
273 (28)
219 (29)
37.4 (8.1)
36.3 (6.9)
1.03 (0.12)
1.64 (0.24)
1.42 (0.23)
1.44 (0.20)
0.229 (0.147)
0.245 ((1.057)
0.016 (0.142)
35
19
297 (65)
213 (18)
206 (32)
34.3 (7.6)
36.3 (7.8)
t).95 (0.14)
1.32 (0.11)
1.14 (0.11)
1.10 (0.11)
0.177 (0.096)
(1.205 (0.045)
0.029 (0.080)
29
16
403 (57)
259 (25)
232 (30)
35.5 (6.0)
36.6 (5.4)
0.97 (0.11)
1.70 (0.18)
1.52 (0.15)
1.50 (0.11)
0.184 (0.132)
0.240 (0.046)
0.055 (0.099)
was considered necessary. Because of the impracticality of waiting
for equilibration to occur (30 to 60 mm post-dialysis) for routine
urea kinetic modeling, a method was sought to approximate this
value that could be carried out in large numbers ot patients in
multiple dialysis centers. Methods chosen were based on double-
pool mathematical approximation of the equilibrated dose of
dialysis (eKt/V-urea) derived from changes in blood urea concen-
tration during dialysis, or from changes in dialysate urea concen-
tration. Three blood side methods and a dialysate-side method
were selected for comparison with results obtained from direct
measurement of the equilibrated BUN. To accomplish this goal,
four pilot centers were selected in which detailed urea kinetic
analyses were performed in relatively small numbers of patients.
METHODS
Pre-Pilot Study
A Pre-Pilot Study was carried out in three of the HEMO Pilot
Study Clinical Centers (Beth Israel Medical Center, New England
Medical Center, and Vanderbilt University) to assess kinetic
modeling methods prior to initiation of the Pilot Study. Two
dialyses in each of 22 patients and a single dialysis in four
additional patients were modeled, for a total of 48 modeled
dialyses. Blood samples for determination of serum urea nitrogen
(BUN) were drawn predialysis, at 70 minutes into dialysis, imme-
diately post-dialysis, and at 2, 5, 10, 15, 20 and 30 minutes
post-dialysis. To minimize the dilutional effects of potential access
reeireulation, the sample obtained during dialysis as well as the
immediate post-dialysis sample were drawn from the arterial line
sampling port after the blood flow had been reduced to 100
mi/mm for approximately 10 seconds.
Pilot Study
The Pilot Study was carried out at four Clinical Centers (Beth
Israel, Harbor Medical Center; University of Southern California;
New England Medical Center; and Vanderbilt University). The
purposes of the Pilot Study were to test the feasibility of the
protocol, evaluate the adequacy of the data entry forms, and to
provide additional data with which to select the method for
quantitating dialysis during the Full-Scale Study. A total of 49
patients were enrolled of which 24 were diabetic, 20 were female,
and 24 were Caucasian.
After enrollment each patient remained on his or her usual
dialysis prescription for approximately three weeks, during which
urea kinetics were modeled for three to four dialysis sessions.
Subsequently, urea modeling was done during at least two addi-
tional baseline dialyses at a target equilibrated Kt/V of 1 .4 based
on dialysis prescriptions provided by the Data Coordinating
Center (Cleveland Clinic Foundation), which were prepared using
estimated dialyzer clearances and values for urea distribution
volume obtained from the initial modeling studies. A requirement
for randomization included achieving an equilibrated Kt/V of at
least 1.3 during each of two different modeled dialyses. Thirty-
eight of the 49 enrolled patients successfully achieved this goal
and were randomized to equilibrated Kt/V goals of either it) or
1.4 per dialysis, after which two additional dialyses were modeled.
in the Pilot Study design, an attempt was made to keep the dialysis
treatment time similar at the two Kt/V levels; hence, the rate of
dialysis, or K/V, differed between the two Kt/V treatment arms.
The number of dialysis sessions at each point are listed in Table 1.
Of the 49 patients studied, complete baseline data on the usual
prescription were available for 144 dialysis sessions in 48 patients.
In 46 patients (87 sessions) data were available from the baseline
period when trying to achieve the eKt/V goal of 1.4. From the
follow-up period, once randomized into the standard and high
eKt/V goals, data were available in 19 and 16 patients, from 35
and 29 sessions, respectively.
For the Pilot Study, the set of blood samples drawn during and
after dialysis was different than the set drawn during the Pre-Pilot
Study. An "immediate" post-dialysis sample was drawn approxi-
mately 10 seconds after slowing blood flow to 100 mI/mm (as in
the Pre-Pilot Study), but only one delayed post-dialysis sample
was obtained 30 minutes after stopping dialysis because, as
Data are mean + so. The data are summariLed on a patient basis; that is, the means and standard deviations are provided for the average values of
the kinetic parameters computed for each patient during each of the indicated periods of the study.
Computed using the 2-pool model with the 30 minute post-BUN
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described under the Results section below, the Pre-Pilot Study
showed that collection of the six BUN measurements between 2
and 30 minutes after dialysis provided little additional information
regarding the equilibrated post-dialysis BUN beyond that pro-
vided by the 30 minute sample alone.
In the Pilot Study the pattern of intradialytic samples was also
different from the Pre-Pilot Study. During the baseline (pre-
randomization) phase of the Pilot Study, blood for BUN was
drawn pre-dialysis, 70 minutes into dialysis, and also at 60% and
80% of the total treatment time into dialysis, to attempt to
determine the optimum timing of an intradialytic sample. After
randomization in the Pilot Study, based on a preliminary analysis
of the data, the later intradialytic samples were no longer ob-
tained, and only one intradialytic sample was drawn 70 minutes
after the start of dialysis.
BUN was measured in all serum samples at a central laboratory
(Spectra Laboratories, Fremont, CA, USA). For the Pilot Study,
in addition to the blood sided measures of urea, the BioStat
device [4] (Baxter Healthcare, Inc., Deerfield, IL, USA) was used.
This instrument measures dialysate urea concentration on line at
5 to 10 minute intervals (using urease and an ammonium-sensitive
electrode) throughout the treatment and provides and indepen-
dent check of delivered dialysis therapy.
Blood side methods for estimating eKt/V
Two-pool model with seven post-dialysis BUNs. With this
method, used only during the Pre-Pilot Study, a 2-pool variable
volume model of hemodialysis urea kinetics [5—8] was fit to the
BUN values measured pre-dialysis, immediately post-dialysis, and
at 2, 5, 10, 15, 20 and 30 minutes post-dialysis as follows. For each
modeled dialysis, the in vivo blood water dialyzer clearance was
estimated from the blood and dialysate flows and the in vitro
dialyzer KoA using standard formulae [9] with appropriate ad-
justments for blood water concentration [10, 11] and ultrafiltra-
tion. The computed dialyzer clearance (Kd), the pre-dialysis
BUN, the estimated equilibrated urea generation rate, and the
ultrafiltration rate calculated from weight loss during dialysis were
then used as inputs along with trial estimates of the intercompart-
ment transfer coefficient (1(c) and total urea volume (V) to
numerically solve the 2-pool variable volume model to predict
values for the seven postdialysis BUNs. The ratio of the intracel-
lular and extracellular volumes was assumed to be 2 to 1 [61. To
account for rebound due to cardiopulmonary recirculation [121,
the model allowed for a change in the predicted BUN between the
immediate post-dialysis and the two minute post-dialysis BUN.
Optimal values of Kc and V were then derived using numerical
methods to produce predicted BUNs with the minimum sum of
squared deviations from the actually observed values. Based on
the optimal Kc and V, the equilibrated (2 hour) post-dialysis BUN
(Ceq) was estimated and corrected for urea generation. This
estimate of Ceq was then substituted for the post-dialysis BUN
using Depner's 2-BUN algorithm [81 for computing eKt/V. In this
application of the 2-BUN method, the pre-dialysis BUN, the
estimated Ceq, the modeled urea distribution volume (V), the
weight change during dialysis and the duration of dialysis were
used as inputs to compute eKt/V.
Two-pool model with 30 minute post-dialysis BUN. A numerical
approach similar to the above was used, except that the optimal
Kc and V were obtained by fitting the 2-pool variable volume
model to the pre-dialysis, immediate post-dialysis (after adjust-
ment for cardiopulmonary recirculation), and the 30 minute
post-dialysis BUNs. The immediate post-dialysis BUN (C1) was
adjusted (Ctadj) for cardiopulmonary recirculation [12] by:
Ctadj = C1/Fcp,
Fcp = 1/111 + KAc/(CO — 0AC)]'
where KAC is the access clearance (assumed to be equal to the
dialyzer clearance Kd), CO is the cardiac output (determined
from anthropometric body surface area multiplied by a presumed
population mean cardiac index of 3.0 [13]) and 0AC is the access
flow (assumed to be 800 ml/min [14, 15]). One complication of this
method is that often there are two solutions giving an exact fit to
the observed BUNs: one with V relatively close to the standard
single pool volume and Kc between 150 mI/mm and + infinity;
and the other with V 30% to 50% smaller than the single pool
volume and Kc between 10 and 100 mI/mm. In the latter solution
with the smaller Kc, the total predicted rebound is typically very
large and occurs over several hours, with only a small fraction of
the rebound occurring by 30 minutes post-dialysis. Due to its
greater biological plausibility and close correlation with the 2-pool
model with seven post-dialysis BUNs from the Pre-Pilot Study,
the solution with the larger Kc was used in the analyses reported
here.
Methods not requiring delayed post-dialysis sampling
Rate adjustment method. The rate adjustment method [16] is
based on a regional blood flow model. It predicts that the
magnitude of post-dialysis urea rebound is related to the rate of
dialysis or dialysis efficiency (K/V). The rate equation predicts the
equilibrated Kt/V from the rate of dialysis (K/V) and the single-
pool Kt/V (spKt/V). The equation used was:
eKt/V = spKt/V — 0.6 x (spKtJV)/hours + 0.03
The spKt/V was computed from the Depner 2-BUN equations [8]
using an estimated Kd as described above. The equilibrated Kt/V
was then computed from the spKt/V and the duration of dialysis.
Smye method. The Smye method [17, 18] is based on the notion
that compartment disequilibrium during dialysis produces a devi-
ation from the expected monoexponential fall in the serum BUN,
and the extent of this deviation can be used to predict the
equilibrated post-dialysis BUN value. According to Smye and
colleagues, the equilibrated postdialysis BUN (Ceq) is defined as:
Ceq = C0>< exp[—Td/(Td — 70) X log(C./C1)]
where Td = treatment time, C70 is the 70-minute intradialysis
BUN, and C11 and C1 are the pre-dialysis and post-dialysis BUN,
respectively. The equilibrated Kt/V was computed from Ceq, the
predialysis BUN, and V using the same algorithm used for the
other blood-side methods described above.
Two-pool model with three intradialysis BUNs. An approach
similar to the 2-pool model with seven post-dialysis BUNs was
used, except that the 2-pool variable volume model was fit to the
BUNs obtained pre-dialysis, at 70 minutes, at 60% and 80% of the
time into dialysis, and immediately post-dialysis. The rationale for
the method is that the same factors that cause post-dialysis urea
rebound conspire to reduce the intradialytic BUN profile from a
monoexponential fall. Making the assumption that the intercom-
partmental mass transfer coefficient (Kc) is stable during dialysis,
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the Kc, and subsequently the post-dialysis urea rebound can be
computed from the degree of deviation of the intradialytic BUN
profile from a monoexponential decline.
BioStat method. The BioStat device [4] calculates the eKt/V
from a double exponential curve fit of the effluent dialysate
concentration-time profile. The early, steep slope of the concen-
tration-time profile represents the preferential removal of urea
from an easily accessible compartment and the late, shallower
slope represents removal from a larger volume of distribution that
includes both the easily accessible compartment and a poorly
accessible compartment. In a patient with a large dialysis induced
concentration disequilibrium between body compartments (hence
the large post-dialysis urea rebound), the ratio of the early to late
slope is much greater than 1.0. Patients with a small post-dialysis
urea rebound have a slope ratio closer to 1, indicating less
disequilibrium between the two compartments.
Data analysis
Standards for comparison. For analyses of the Pre-Pilot data, the
estimate of eKt/V from the 2-pool model with seven postdialysis
BUNs was regarded as the reference standard. For the Pilot
Study, the estimate of eKt/V from the 2-pool model with the
single 30-minute postdialysis BUN was used as the reference
standard, as the Pre-Pilot data indicated that the latter estimate
agreed well with the eKt/V derived from the 7 postdialysis BUNs
(see Results section, below). In the Pre-Pilot and Pilot studies,
respectively, these two methods were used as the standard for
comparison with other estimates of eKt/V that were based on
intradialysis BUN measurements, the rate equation, or dialysate
urea measurements.
Statistical analysis. Comparisons of different estimates of eKt/V
were made using the Pearson correlation coefficient (Re), and the
following alternative measures of association or agreement:
(i) Spearman correlation coefficient (Rb) [19]: Index of direct
association (possibly non-linear) between two methods; less af-
fected by outliers than the Pearson correlation.
(ii) Concordance statistic (Re) [201: Index of agreement between
the methods. It is equal to 1 if there is perfect agreement, and
takes on smaller values otherwise. If there is no systematic bias,
the concordance statistic is equal to the Pearson correlation;
otherwise, the magnitude of the concordance statistic is smaller,
as it reflects both association and systematic bias between meth-
ods.
(iii) Median algebraic difference (median ): Median of the
differences between eKt/V estimates as computed by two meth-
ods. This is an index of systematic bias of one method with respect
to the other.
(iv) Median absolute difference (median I): Absolute value of
(iii), above. This is an index of agreement between methods.
The bootstrap method [211 with 1,200 independent bootstrap
samples was used for statistical comparisons of these measures of
agreement between different pairs of estimates of eKt!V. The
bootstrap method does not require the assumption of normality,
which is violated by several of the measures of agreement
considered. The bootstrap approach also allowed us to account
for multiple measurements per patient by drawing the bootstrap
samples on a patient basis, so that all dialysis sessions for a given
patient were jointly included or excluded in each bootstrap
sample. The results of these comparisons are described in the
footnotes to Tables 2, 3, and 6.
For the Pre-Pilot Study, statistical analyses were restricted to 42
of the 48 modeled dialyses during which all scheduled blood
samples were obtained. For the Pilot Study, analyses were re-
stricted to 295 dialyses with complete kinetic modeling data,
including a valid BioStat analysis and the pre-dialysis, 70 minute
intradialysis, immediate post-dialysis, and 30-minute post-dialysis
BUN samples. As noted above, the two additional intradialytic
samples (used for the 2-pool model with 3 intradialysis BUNs)
were not obtained in the approximately 60 sessions quantified
after randomization.
Estimates of eKt/V were compared first for all dialyses and then
for individual patients after averaging the results of the three to
four modeled dialyses conducted during baseline on the patient's
usual prescription. In the Pilot Study analyses, agreement was
summarized first for all dialyses and then again after excluding
sessions with "deviant" profiles of the BUN or dialysate urea
concentrations (see below).
Linear regression analyses were performed to relate Kt/V =
sp(Kt/V) — eKt!V to various dialysis parameters. Mixed effects
models [22] with a random coefficient for each patient were used
to account for correlations in Kt/V among dialysis sessions
conducted in the same patient.
"Deviant" blood and dialysate profiles defined. A BUN profile
was defined as "deviant" if the residual sum of squares for the
2-pooi model with the 30-minute postdialysis BUN exceeded 0.012
(mg/dl)2. For these BUN profiles the post-dialysis rebound was
either too small (or negative) or was too large to be accounted for
by the two-pool variable-volume model. Dialysate urea nitrogen
profiles that were "deviant" were also treated separately in some
analyses. Built into the BioStat is a quality assurance algorithm
that rejects concentration measurements that markedly deviate
from the predicted concentration-time profile. Urea nitrogen
measurements below 3 mg/dl (low limit of the instrument) are also
rejected because of inaccuracies in urea nitrogen levels this low.
If, in a given dialysis treatment, more than four samples are
rejected by this criterion, the run is flagged with the message "Fit
Error," indicating an unstable run with significant deviations from
the predicted concentration-time profile. Causes for an unstable
run include frequent and prolonged machine alarms with dialysate
bypass/blood pump shutdown, mid-run changes in dialysis param-
eters (such as blood flow), vascular access problems, dialyzer
clotting, hypotensive episodes, etc. Such "Fit Errors" were treated
as "deviant" in a similar fashion to deviant blood sided values.
RESULTS
Prepilot data analysis
Two-pool model with 7 postdialysis BUNs compared to the
two-pool model with a 30 minute post-dialysis BUN. In the 42
sessions with complete data, there was excellent agreement be-
tween the eKt/V values computed using the 2-pooi model with a
30 minute post-dialysis BUN and the eKt/V values computed
using the 30 minute post-dialysis BUN plus the additional five
BUNs from samples drawn between 0 and 30 minutes post-
dialysis. The correlation coefficients were: R (Pearson) 0,985,
R5 (Spearman) = 0.975, and R (concordance) = 0.984. The
median absolute difference between the two eKt/V measures was
0.013 Kt/V units. Thus the Pre-Pilot Study data indicated that the
two methods generated similar eKt/Vs. Since the 2-pool model
with a single 30 minute post-dialysis BUN is much simpler to
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perform, it was used as the reference standard in the subsequent
Pilot Study.
Pilot data analyses
Patient characteristics. As shown in Table 1, the mean SD
delivered Kt/V calculated at baseline using single-pool kinetics
was 1.49 0.21. The mean duration of dialysis was 210 27
minutes. The mean single-pool urea distribution volume was
35.1 6.4 liters, with a mean modeled/anthropometric volume
ratio of 0.99 0.14. Based on the 2-pool model with the 30
minute post-BUN, (the blood side standard), the delivered equil-
ibrated Kt/V values after randomization were near the target
values of 1.0 and 1.4 per dialysis. Although both goals were slightly
exceeded at 1.14 0.11 and 1.52 0.15, there was a clear
separation of the Kt/V values in the two groups, demonstrating
the feasibility of achieving the Kt/V goals of the study.
Accuracy of the various blood-side modeling methods. The true
equilibrated Kt/V value obtained from the 2-pool model with the
30 minute post-dialysis BUN is compared with various blood-side
estimates in Figures 1 through 3 and in Tables 2 and 3. In Figures
1 through 4, the upper graph shows all modeled sessions (columns
A through D in Table 1), including deviant sessions as defined
above. The deviant sessions are identified as hollow circles but not
excluded from the analysis. The lower graphs in Figures 1 through
4 include only modeled sessions obtained during the baseline
period on a constant (the patient's usual) prescription (column A
in Table 1). This is necessary as eKt/V results are averaged in the
lower graphs on a patient basis, and hence the prescription must
be held constant. In all of the lower graphs in Figures 1 through
4, deviant sessions are excluded from the averaging process.
Both the rate equation (Fig. 1) and the two methods based on
BUN values during dialysis (Smye method in Fig. 2, and the
2-pool model with 3 intradialysis BUNs in Fig. 3) predicted eKt/V
quite well. On an individual dialysis session basis, the rate
equation predicted eKt/V significantly better (P < 0.05) than the
other two blood based methods (Table 2). Averaging across the
baseline sessions on the usual prescription improved the accuracy
of the Smye method and the 2-pool model with three intradialysis
BUNs to a greater extent than than the rate equation method.
After averaging, the performance of the three blood side methods
was similar, with no statistically significant differences among the
methods on any of the indices of agreement considered (Table 3).
The data in the Figures 1 through 3 and Tables 2 and 3
overestimate the ability of the rate equation and intradialytic
methods to predict the zKt/V (the difference between single pool
and equilibrated Kt/V), as they focus on the eKt/V. This is
because computed values of eKt/V usually fall within 0.4 Kt/V
units of the single-pool KtIV, regardless of which method is used
to estimate eKt/V. Thus, in any data set with a substantial range
of single-pool Kt/V values, resultant eKt/V values computed by
different techniques can he expected to have relatively high
correlations. A more stringent test of the rate equation is to
analyze how well the difference between single-pool Kt/V and
eKt/V, or the Kt/V, can be predicted from K/V and related
parameters. Such an analysis is done in Tables 4 and 5 on a session
basis, using all sessions (Table 4, N = 295), and using only
non-deviant sessions (Table 5, N = 262).
When all sessions were analyzed, the univariate association
(Pearson R value) between K/V and Kt/V was 0.40. The
correlation coefficient increased to 0.56 when data from deviant
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Fig. 1. Comparison of the true equilibrated eKt/V (based on the 2-pool
model with the 30 mm post-BUN) with results of the rate adjustment
method. In Figures 1—4, the dashed lines indicate deviations of 0.2 Kt/V
units. On the upper panel (A) of each figure, all sessions (baseline and
follow-up, columns A—D in Table 1) are graphed. Deviant sessions (see
text) are marked by open circles (0) but are not excluded from the
analyses computing the correlation coefficients or mean/median differ-
ences. On the lower panel (B), only the baseline sessions on the usual
dialysis prescription (column A in Table 1) are analyzed. Here the
sessions are averaged after excluding deviant sessions to compute
individual patient means, and the latter are graphed. (A) N = 295
session in 49 patients, R = 0.854, R5 = 0.868, R = 0.843, Med =
—0.04, Med = 0.064, R (deviant sessions removed) = 0.919. (B)N = 41 patients (averages taken over 117 sessions, with deviant session
excluded), R 0.960, R = 0.961, R = 0.954, Med = —0.02, Mcd
= 0.037.
'p
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Table 2. Comparison of blood-sided measurements with the true equilibrated eKt/V: Analysis by individual dialysis session
Table 3. Comparison of blood-side estimates with the true equilibrated eKt/V: Analysis by patient, after averaging eKt/Vs for 3—4 baseline dialyses
at usual prescription (column A in Table 1)
All modeled dialysesa
Sessions with deviant
BUNs removed
R R5 R Medz Med R
Rate equation'
Smy&'
0.89
0.92
0.88
0.91
0.88
0.90
—0.010
—0.024
0.048
0.051
0.96
0.94
Two-pool model with 3 0.87 0.89 0.85 —0.028 0.048 0.91
intradialysis BUNsC
With all modeled dialyses included, R, R, R, Med z and Med4 did not differ significantly between the Rate equation, the Smye, and the 2-pool
model with 3 intradialysis BUNs
h Including deviant sessions, N = 131 baseline dialyses in 41 patients; excluding deviant sessions, N = 117 dialyses in 41 patients
Including deviant sessions, N = 129 baseline dialyses in 41 patients; excluding deviant sessions, N = 115 dialyses in 41 patients
Table 4. Univariat&' associations between Kt/V = sp(Kt/V) — eKt/V
and other parameters: All sessions
Parameter Intercept (SE) Slope (SE) R P value
K/V liter/hr
—0.05 (0.05) +0.60 (0.10) + 0.40 <0.0001
Td hr +0.40 (0.07) —0.053 (0.019) —0.20 0.0006
Kd liter/hr +0.04 (0.07) +0.012 (0.004) +0.17 0.003
V(sa) liter +0.39 (0.07) —0.005 (0.002) —0.21 0.0003
Of liter/hr + 0.21 (0.02) + 0.008 (0.023) + 0.03 0.60
N = All 295 sessions in 49 patients (columns A—D in Table 1).
a Univariate associations are presented because functional relationships
among the other parameters preclude a multivariate model including all
parameters. However, in separate regression models conducted with K/V
and each of the other parameters considered one at a time, none of the
remaining parameters were significant after including K/V.
post-dialysis BUN) and eKt/V derived from the dialysate concen-
tration profile is shown in Figure 4. Again, the upper graph shows
all sessions (columns A-D in Table 1) with deviant blood BUN
profiles identified as hollow circles and deviant dialysate profiles
shown as crosses (deviant sessions not excluded from the analy-
sis). The lower graph shows results from baseline modeling
sessions at usual prescription only (column A in Table 1), with the
results averaged by patient after excluding sessions with either
deviant BUN or deviant dialysate urea nitrogen (DUN) profiles.
As shown by Table 6, the BioStat eKt/V was in closer agree-
ment with the blood-side rate equation than with the Smye
method or the 2-pool model with three intradialysis BUNs. As
shown from a comparison of results in Table 6 and Table 2,
Table 5. Univariat& associations between Kt/V = sp(Kt/V) — eKt/V
and other parameters: Deviant sessions removed
Parameter Intercept (SE) Slope (SE) R P value
K/V liter/hr —0.08 (0.03) +0.67 (0.07) +0.56 <0.0001
Td hr +0.37 (0.06) —0.043 (0.015) —0.30 <0.0001
Kd liter/hr +0.03 (0.05) +0.013 (0.003) +0.26 0.0001
V(sa) liter +0.41 (0.06) —0.005 (0.002) —0.31 <0.0001
Of liter/hr + 0.20 (0.02) + 0.025 (0.020) + 0.06 0.33
Deviant BUN sessions removed (n = 262 sessions in 48 patients)
a Univariate associations are presented because functional relationships
among the other parameters preclude a multivariate model including all
parameters. However, in separate regression models conducted with K/V
and each of the other parameters considered one at a time, none of the
remaining parameters were significant after including K/V.
agreement between thc BioStat eKt/V and the blood-side stan-
dard based on the 2-pool model with the 30 mm post-dialysis
BUN (R of 0.68 or 0.76 with and without deviant sessions,
respectively) was similar to the agreement of the rate equation or
intradialytic methods with the 2-pooi model with the 30 mm
post-dialysis (R1, values in the range of 0.76 to 0.85 with deviant
sessions, and 0.82 to 0.92 with deviant sessions removed).
Error analysis: Rate method. Figure 5 shows results of urea
modeling for every dialysis for each patient in a graphic format.
The data are expressed as the difference between the true
equilibrated eKt/V assessed using the 2-pool model with the 30
minute post-dialysis BUN and eKt/V predicted by the rate
equation. Results for modeled dialyses during which the blood
All modeled dialyses'
Method R1 R5 R Med
Sessions with deviant
BUNs removed
Med Rp
Rate equation5
Smy&'
0.85
0.78
0.87
0.78
0.84
0.76
—0.036
—0.056
0.064
0.087
0.92
0.83
Two-pool model with 3 0.76 0.76 0.75 —0.045 0.097 0.82
intradialysis BUNs'
a With all modeled dialyses included, R, R, and R were significantly higher and mcd significantly smaller (P < 0.05) for the rate equation than
for the Smye method and for the 2-poo1 model with 3 intradialysis BUNs. Med was significantly < 0 for each method, indicating each of these methods
slightly underestimated the true eKt/V.
bAll modeled dialyses (columns A—D in Table 1) including deviant sessions, N = 295 sessions in 49 patients, and excluding deviant sessions, N = 262
sessions in 48 patients.
CAll modeled baseline dialyses (columns A—B in Table 1) including deviant sessions, N = 229 sessions in 49 patients, and excluding deviant sessions,
N = 203 sessions in 48 patients. Number of sessions is lower for the 2-pool model with 3 intradialysis BUNs, as procurement of the additional
intradialytic samples required was not done for sessions after randomization.
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True eKtN (2 pool model with 30 mm post)
Fig. 4. Comparison of the true equilibrated eKt/V with results of the
BioStat method. A) N = 295 sessions in 49 patients, R1 = 0.682, R5 =
0.734, R = 0.679, Med A = +0.01, Med = 0.078, r (deviant sessions
removed) = 0.762. (B) N = 41 patients (averages taken over 101 sessions,
with deviant session excluded), R1, = 0.8 13, R5 = 0.812, R = 0.762, Med
A = +0.01, Med Al = 0.076. Symbols are: (0) deviant BUN profile; (+)
deviant DUN profile; () both.
BUN profiles were designated as deviant (fit errors) are shown as
hollow circles. Figure 5 shows that modeled dialyses with fit errors
were distinguishable from the usual values in the majority of
patients.
DISCUSSION
The data suggest that post-dialysis urea rebound is relatively
predictable in the study population that fulfilled enrollment
criteria for the HEMO Pilot Study. Urea rebound could be
predicted from curve fitting techniques that required one or more
intradialysis BUN samples [17, 18], or from the single compart-
ment Kt/V modified with a simple rate equation that was derived
mechanistically from a model of urea kinetics based on regional
blood flow [16, 23—25]. The excellent correlation of the true
equilibrated eKt/V with that predicted by the rate equation
suggests that the rise in BUN from the immediate post-dialysis
period to 30 minutes post-dialysis is a function of the rate of
dialysis (K/V). The rate equation is derived from a regional blood
flow model, and although rebound (as AKt/V) is related to K/V,
the slope term of the equation (the multiplier of the K/V term)
was theorized to depend on the amount of blood flow going to
those body organs in which urea content is high, but which
normally receive only a small fraction of the cardiac output (for
example, muscle). The slope coefficient of 0.60 was derived from
the regional blood flow model based on an assumed cardiac index
of 2.85 liter/min/M2, a fractional flow to the "low flow, high urea
volume" compartment of 15%, and an access blood flow of 800
mI/mm [16, 26]. In a patient with either unusually good or
unusually poor perfusion of the muscle (plus skin and bone)
compartment, the regional blood flow model predicts that the 0.60
multiplier for the K/V term in the rate equation would be
correspondingly lower or higher, reflecting decreased or increased
urea sequestration in these organs. In fact, when a subset of
patients with unusually high cardiac index is studied, rebound is
smaller than that predicted by the rate equation [26]. The present
data suggest that the 0.60 multiplier for the K/V term in the rate
equation, as initially proposed by Schneditz and Daugirdas [24], is
a reasonably good choice overall. The practical benefit is a simple
linear equation (rate equation) that predicts the true equilibrated
eKt/V fairly well. It remains possible that, for individual patients
with unusual hemodynamic values (such as, unusually good or
poor muscle perfusion), the rate equation will systematically and
repeatedly under- or overestimate postdialysis urea rebound.
In designing a large multicenter trial to be carried out in 15
clinical centers, each with three or four dialysis clinics, the
technique for assessing dialysis adequacy should be as simple as
possible. The present study suggests that one need only measure
the pre-dialysis and post-dialysis BUN and rely on expressions
such as the rate equation to predict the effect of post-dialysis urea
rebound on Kt/V.
Our results also suggest that use of one or more intradialysis
BUN samples to estimate urea rebound [18] is a useful means of
estimating the eKt/V. With regard to blood sampling during
dialysis, the data suggest that a single sample obtained 70 minutes
into dialysis affords as much information as multiple samples
obtained throughout the dialysis. When estimating eKt/V for a
single dialysis, the use of one or more intradialytic samples during
dialysis to predict eKt/V was actually less accurate than using only
the pre- and post-dialysis sample and the rate equation. A possible
explanation for this result is that measurement error in the BUNs
and/or physiologic fluctuations during dialysis may increase vari-
ability in methods, such as the Smye method or the 2-pool model
with three intradialysis BUNs, which depend on the accuracy of
session-specific estimates of the intercompartment mass transfer
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Table 6. Comparison of blood-sided measurements with dialysis side eKt/V: Analysis by individual dialysis session
Method
All modeled dialyses"
Sessions with deviant
DUNs and BUNs
removed
RR R5 R Med Med
Two-pool model with 30 mm post-BUN
(blood side standard)"
Rate equation"
Smye"
Two-pool model with 3 intradialysis BUNs"
0.68
0.77
0.64
0.59
0.73
0.78
0.67
0.60
0.68
0.74
0.61
0.57
+0.008
—0.027
—0.049
—0.060
0.078
0.080
0.098
0.099
0.76
0.79
0.67
0.59
With all modeled dialyses included, R5 and R were significantly higher (P < 0.05) for the agreement of the dialysate eKt/V with the rate equation
than for the agreement of the dialysate eKt/V with the remaining three blood sided methods. R was also significantly higher and Med4 significantly
smaller for the agreement of the dialysate eKt/V with the rate equation than for the agreement of the dialysate eKtIV with the Smye or the 2-pool model
with 3 mntradialysis BUNs. Med did not differ significantly from 0 for the true equilibrated eKt/V, indicating no systematic bias between the dialysate
eKt/V and the blood side standard. Med was significantly <0 for the remaining blood side methods, indicating that these methods slightly
underestimated the dialysate eKt/V.
"All modeled dialyses (columns A—D in Table 1) including deviant sessions; N = 295 sessions in 49 patients. Excluding deviant sessions; N = 235
sessions in 48 patients.
C All modeled baseline dialyses (columns A—B in Table 1) including deviant sessions; N = 229 sessions in 49 patients. Excluding deviant sessions; N =
182 sessions in 47 patients.
Fig. 5. Analysis by individual patient and by center of the difference
between the true equilibrated eKt/V and eKt/V calculated from the simple
rate equation. All sessions (baseline and follow-up, columns A—D in Table
1) are graphed. Deviant sessions (see text) are marked by open circles (0).
The mean Kt/V difference for sessions with non-deviant BUN profiles are
indicated by vertical bars. Sample size: 295 sessions in 49 patients.
coefficient Kc. By contrast, as described above, the rate equation
assumes a constant level of solute disequilibrium that does not
vary from session to session. The use of a fixed index of solute
disequilibrium in the rate equation should produce less variable
estimates of eKt/V for individual dialysis sessions, albeit possibly
at the cost of bias in patients with unusual hemodynamic param-
eters. This explanation is supported by the observation that
averaging eKt/Vs over three to four dialysis sessions improved the
performance of the Smye method and the 2-pooi model with three
intradialysis BUNs to a level similar to that of the rate equation
method (Table 3). That is, it appears that averaging results across
several dialysis sessions smoothed out the variability induced by
unstable estimates of Kc for the Smye method and the 2-pool
model with three intradialysis BUNs.
One criticism of the design of the present studies is that blood
was sampled only at 30 minutes after dialysis. Multicompartment
models of urea kinetics predict that the degree to which rebound
is complete at 30 minutes (usually 85 to 90%) depends on the
intercompartment urea mass transfer coefficient, Kc, in addition
to K/V. In theory, estimation of the equilibrated BUN from a
single 30-minute post-dialysis BUN sample is problematic. This
error could be reduced, although not eliminated, by waiting a full
hour after dialysis to obtain a sample. Unfortunately, based on
feedback from the clinical centers, it was deemed impractical to
ask that the patients remain for a full hour after dialysis on
multiple occasions. Hence a compromise time of 30 minutes
post-dialysis was decided upon. Our analytical methods were
designed to address the problem of incomplete rebound at 30
minutes. As discussed in the Methods section, there is a unique
solution, or at most two solutions, for the classic 2-compartment
model fitting values for the pre-dialysis BUN, the post-dialysis
BUN, and the 30 minute post-dialysis BUN. When two solutions
are found, one can be discarded because it requires a urea
distribution volume that is far removed from the predicted
anthropometric value. Thus, in a patient with a low value for Kc,
the difference between the post-dialysis BUN and the 30 minute
post-dialysis BUN will be larger (for similar values of K/V) than in
a patient with a high value for Kc. Because the fractional
completion of rebound at 30 minutes depends on Kc, both Kc and
the 60 minute rebound value can he solved for iteratively,
eliminating a bias that might be caused by an assumption that
rebound is universally 85 to 90% complete 30 minutes after
dialysis. An unproven assumption upon which the reliability of the
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iterative curve fitting method depends is that the patient's urea
kinetics strictly conforms to a two-compartment variable volume
model. We have since obtained data in a subset of patients studied
at 60 minute post-dialysis suggesting that the computational
methods described here using a 30 minute post-dialysis BUN
sample have an accuracy similar to that obtained using a 60
minute post-dialysis sample to predict the eKt/V (data not
shown).
In this study a dialysate-based method of urea modeling was
also assessed (BioStat, Baxter Healthcare, Inc.). There was little
systematic difference in the mean equilibrated Kt/V values ob-
tained from blood-side versus dialysate-side modeling, confirming
reports by others that blood side modeling or dialysate modeling
can be used to obtain equivalent equilibrated Kt!V values if the
proper corrections are made for urea generation, urea removed
during ultrafiltration, and post-dialysis urea rebound [27—291.
The correlations between the various blood-side methods in our
study were higher than between the blood-sided methods and the
dialysate-side measurement (BioStat). This finding is not unex-
pected, given that high correlations among the blood-sided meth-
ods of modeling are due partly to "mathematical coupling" among
the blood-side methods due to common BUN inputs. For exam-
ple, the Smye and the blood-side standard method based on the
2-pool model with the 30 minute post-BUN have the same input
values for the pre- and post-BUN. Also, the blood-sided methods
share a common Kd as input. A further bias is introduced in those
analyses where "deviant" blood BUN profiles were removed.
Although Figure 5 suggests that such sessions probably repre-
sented technical error in dialysate delivery or blood sampling, by
screening "deviant" BUN profiles that are primarily a conse-
quence of an aberrant relationship between the post-BUN and the
30 minute post-BUN values (negative or extremely large re-
bounds), one selects those sessions where the 30 minute post-
BUN is strongly associated with the post-BUN. Where this
screening was not performed, the correlations among the various
blood side methods were reduced (compare the correlations
computed with and without exclusion of the deviant sessions in
Tables 2 and 3).
Because eKt/V could be measured several times on different
occasions in the same patient, the data provided some insight
regarding the stability and reproducibility of post-dialysis urea
rebound from dialysis to dialysis. If one accepts the general
principle of the rate equation, then Kt/V (the difference between
single-pool Kt/V and eKt/V) is mainly determined by the rate of
dialysis, or K/V. Figure 5 gives some measure of the residual
variability within and among patients in KtN once the K/V
effect has been controlled for. In Figure 5, we subtract estimated
Kt/V based on K/V from the actual LKt/V. It can be seen that on
average, post-dialysis urea rebound was predictable for most
patients, although it was not uncommon to have one or more
sessions that were deviant (hollow circles in Figure 5), the BUN
values of which could not be fit with the standard 2-pooi urea
model.
Based on the results of this Pilot Study, a decision was made to
calculate the dose of each dialysis during the Full Scale HEMO
Study from a single-pool Kt/V corrected to the equilibrated Kt/V
value using the rate equation, and to perform periodic validations
of the rate equation assumptions using the Smye technique,
occasional 30 minute post-dialysis samplings and, in a subset of
patients, 60 minute post-dialysis samplings for BUN. A dialysate
method using multiple dialysate urea samplings (BioStat) is also
being used to validate the rate equation method in a subset of
patients.
In summary, our results suggest that, in a dialysis patient
population selected for ability to achieve an equilibrated Kt/V of
about 1.45 in less than a 4.5 hour period, use of the pre- and
post-dialysis samples and a kinetically-derived rate equation gives
reasonably good prediction of equilibrated Kt/V. Addition of one
or more intradialytic samples does not appear to increase accu-
racy of predicting the equilibrated KtIV in the majority of
patients. A method based on dialysate urea analysis and curve-
fitting yields results for equilibrated Kt/V that are similar to those
obtained using exclusively blood-based methods of kinetic mod-
eling.
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